About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Ins1tm1.1(cre)Thor
targeted mutation 1.1, Bernard Thorens
MGI:5614359
Summary 7 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
ht1
Ins1tm1.1(cre)Thor/Ins1+ involves: C57BL/6J MGI:5614450
cn2
Nnattm1.1Geno/Nnat+
Ins1tm1.1(cre)Thor/Ins1+
involves: 129S2/SvPas * C57BL/6J MGI:6715257
cn3
Clic4tm1.1Thor/Clic4tm1.1Thor
Ins1tm1.1(cre)Thor/Ins1+
involves: C57BL/6J MGI:5903885
cn4
Ins1tm1.1(cre)Thor/Ins1+
Syt13tm1c(EUCOMM)Hmgu/Syt13tm1c(EUCOMM)Hmgu
involves: C57BL/6J * C57BL/6N MGI:7751429
cn5
Ins1tm1.1(cre)Thor/Ins1+
Tpcn2tm1c(EUCOMM)Hmgu/Tpcn2tm1c(EUCOMM)Hmgu
involves: C57BL/6J * C57BL/6N MGI:5806431
cn6
Ins1tm1.1(cre)Thor/Ins1+
Larp1tm1c(EUCOMM)Hmgu/Larp1tm1c(EUCOMM)Hmgu
involves: C57BL/6J * C57BL/6N MGI:6506683
cn7
Ins1tm1.1(cre)Thor/Ins1+
Med15tm1c(KOMP)Wtsi/Med15tm1c(KOMP)Wtsi
involves: C57BL/6J * C57BL/6N MGI:7788882


Genotype
MGI:5614450
ht1
Allelic
Composition
Ins1tm1.1(cre)Thor/Ins1+
Genetic
Background
involves: C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ins1tm1.1(cre)Thor mutation (4 available); any Ins1 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
N
• mice exhibit normal body weight

homeostasis/metabolism
N
• mice exhibit normal random fed glycemia levels and glucose tolerance




Genotype
MGI:6715257
cn2
Allelic
Composition
Nnattm1.1Geno/Nnat+
Ins1tm1.1(cre)Thor/Ins1+
Genetic
Background
involves: 129S2/SvPas * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ins1tm1.1(cre)Thor mutation (4 available); any Ins1 mutation (46 available)
Nnattm1.1Geno mutation (0 available); any Nnat mutation (15 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• locus is maternally imprinted with no gene expression detectable in mice that have paternally inherited the mutant allele

endocrine/exocrine glands
• mice inheriting the allele paternally exhibit impaired glucose-stimulated insulin secretion
• mice with the paternally inherited allele do not show a normal hyperinsulinemic response to Western diet exposure, with persistence of the defect in glucose-stimulated insulin secretion seen on chow diet
• pancreatic beta cells from mice with the paternally inherited allele show a 2-fold increase in insulin secretion with high glucose compared to 7.2-fold increase by wild-type cells

homeostasis/metabolism
• mice inheriting the allele paternally exhibit impaired glucose-stimulated insulin secretion
• mice with the paternally inherited allele do not show a normal hyperinsulinemic response to Western diet exposure, with persistence of the defect in glucose-stimulated insulin secretion seen on chow diet
• pancreatic beta cells from mice with the paternally inherited allele show a 2-fold increase in insulin secretion with high glucose compared to 7.2-fold increase by wild-type cells
• fasting blood glucose progressively increases in mice that inherit the paternal allele during exposure to Western diet
• progressive deterioration of glucose tolerance is seen over 12 weeks in males with the paternal allele on the Western diet
• however, glucose tolerance is unaffected in chow-fed mice with the paternal allele
• however, no differences in body weight or insulin sensitivity are seen on the Western diet in mice with the paternally inherited allele, suggesting a decline in beta cell function




Genotype
MGI:5903885
cn3
Allelic
Composition
Clic4tm1.1Thor/Clic4tm1.1Thor
Ins1tm1.1(cre)Thor/Ins1+
Genetic
Background
involves: C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Clic4tm1.1Thor mutation (1 available); any Clic4 mutation (41 available)
Ins1tm1.1(cre)Thor mutation (4 available); any Ins1 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
N
• when fed a high fat diet, mice show no differences in beta cell mass or in glucose tolerance and insulin secretion following intraperitoneal glucose injections relative to similarly treated control mice

endocrine/exocrine glands
• primary pancreatic islet cells exhibit reduced sensitivity to cytokines- or palmitic acid-induced apoptosis, as measured by a TUNEL assay
• islets show increased expression of the anti-apoptotic proteins Bcl2, Bcl2l1 (Bcl-xL), as well as increased expression and phosphorylation of Bad, which inhibits its pro-apoptotic activity

cellular
• primary pancreatic islet cells exhibit reduced sensitivity to cytokines- or palmitic acid-induced apoptosis, as measured by a TUNEL assay
• islets show increased expression of the anti-apoptotic proteins Bcl2, Bcl2l1 (Bcl-xL), as well as increased expression and phosphorylation of Bad, which inhibits its pro-apoptotic activity




Genotype
MGI:7751429
cn4
Allelic
Composition
Ins1tm1.1(cre)Thor/Ins1+
Syt13tm1c(EUCOMM)Hmgu/Syt13tm1c(EUCOMM)Hmgu
Genetic
Background
involves: C57BL/6J * C57BL/6N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ins1tm1.1(cre)Thor mutation (4 available); any Ins1 mutation (46 available)
Syt13tm1c(EUCOMM)Hmgu mutation (0 available); any Syt13 mutation (22 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
N
• mice show normal endocrine cell egression and normal numbers of pancreatic alpha and beta cells




Genotype
MGI:5806431
cn5
Allelic
Composition
Ins1tm1.1(cre)Thor/Ins1+
Tpcn2tm1c(EUCOMM)Hmgu/Tpcn2tm1c(EUCOMM)Hmgu
Genetic
Background
involves: C57BL/6J * C57BL/6N
Cell Lines HEPD0665_2_C10
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ins1tm1.1(cre)Thor mutation (4 available); any Ins1 mutation (46 available)
Tpcn2tm1c(EUCOMM)Hmgu mutation (2 available); any Tpcn2 mutation (52 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• mice are overtly normal and exhibit normal growth rates and intraperitoneal and oral glucose tolerance with no differences in glucose-induced Ca2+ dynamics or insulin secretion in isolated islets relative to control mice
• mutant islets show normal glucagon-like peptide-1 (GLP-1)-induced Ca2+ dynamics and insulin secretion, with a similar increase in GLP-1-induced Ca2+ oscillation frequency during moderate glucose stimulation relative to control islets




Genotype
MGI:6506683
cn6
Allelic
Composition
Ins1tm1.1(cre)Thor/Ins1+
Larp1tm1c(EUCOMM)Hmgu/Larp1tm1c(EUCOMM)Hmgu
Genetic
Background
involves: C57BL/6J * C57BL/6N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ins1tm1.1(cre)Thor mutation (4 available); any Ins1 mutation (46 available)
Larp1tm1c(EUCOMM)Hmgu mutation (0 available); any Larp1 mutation (56 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
N
• despite an 80% reduction in Larp1 expression by islets, male mice exhibit no difference in glucose tolerance relative to control males




Genotype
MGI:7788882
cn7
Allelic
Composition
Ins1tm1.1(cre)Thor/Ins1+
Med15tm1c(KOMP)Wtsi/Med15tm1c(KOMP)Wtsi
Genetic
Background
involves: C57BL/6J * C57BL/6N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ins1tm1.1(cre)Thor mutation (4 available); any Ins1 mutation (46 available)
Med15tm1c(KOMP)Wtsi mutation (0 available); any Med15 mutation (50 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
N
• at 8 weeks of age, pancreata show normal gross islet morphology with no change in the number of insulin-positive beta cells, glucagon-positive alpha cells, or total pancreatic cells relative to controls
• RNA-seq on islets of 8-week-old mice shows downregulation of beta-cell maturation markers, including Ucn3 (urocortin 3), Mafa (MAF bZIP transcription factor A), Slc2a2/Glut2 [solute carrier family 2 (facilitated glucose transporter, member 2], Slc30a8 [solute carrier family 30 (zinc transporter), member 8], Iapp (islet amyloid polypeptide), and Ero1b (endoplasmic reticulum oxidoreductase 1 beta)
• islets of 8-week-old mice show significantly fewer and smaller dense core insulin granules, indicating impaired mature insulin secretory granule formation and beta-cell maturation
• at P1 to 8 weeks of age, islets show complete loss of Mafa, Ucn3, and Slc2a2/Glut2 immunostaining (markers of glucose-responsive beta-cells)
• pancreatic islets show reduced glucose-stimulated oxygen consumption but no change in maximal respiration (after addition of FCCP)
• islets show significantly reduced mitochondrial membrane potential upon stimulation with glucose, but not following stimulation with the mitochondrial substrate alpha-ketoglutarate
• at 3 weeks of age, pancreatic beta cell proliferation is significantly increased, as assessed by EdU incorporation into nuclei
• in perifusion assays, pancreatic islets of 8-week-old mice stimulated with 25 mM glucose show impaired first- and second-phase insulin secretion, with no significant change in total insulin content
• however, islets stimulated with alpha-ketoglutarate or KCl show normal insulin secretion, suggesting a defect upstream of mitochondrial metabolism

homeostasis/metabolism
• in perifusion assays, pancreatic islets of 8-week-old mice stimulated with 25 mM glucose show impaired first- and second-phase insulin secretion, with no significant change in total insulin content
• however, islets stimulated with alpha-ketoglutarate or KCl show normal insulin secretion, suggesting a defect upstream of mitochondrial metabolism
• at 3 and 8 weeks of age, both male and female mice show significantly decreased serum insulin levels at time 0 (fasting) and 10 min after intraperitoneal glucose injection
• at 3, 6, and 8 weeks of age, intraperitoneal glucose tolerance tests show that both male and female mice are severely glucose intolerant

cellular
• pancreatic islets show a significant reduction in mitochondrial count per cell relative to control islets
• pancreatic islets show a significant increase in average mitochondrial volume relative to control islets
• islets of 8-week-old mice show significantly fewer and smaller dense core insulin granules, indicating impaired mature insulin secretory granule formation and beta-cell maturation
• at P1 to 8 weeks of age, islets show complete loss of Mafa, Ucn3, and Slc2a2/Glut2 immunostaining (markers of glucose-responsive beta-cells)
• RNA-seq on islets of 8-week-old mice shows downregulation of beta-cell maturation markers, including Ucn3 (urocortin 3), Mafa (MAF bZIP transcription factor A), Slc2a2/Glut2 [solute carrier family 2 (facilitated glucose transporter, member 2], Slc30a8 [solute carrier family 30 (zinc transporter), member 8], Iapp (islet amyloid polypeptide), and Ero1b (endoplasmic reticulum oxidoreductase 1 beta)
• at 3 weeks of age, pancreatic beta cell proliferation is significantly increased, as assessed by EdU incorporation into nuclei
• dispersed pancreatic islets from 8-week-old mice show significantly reduced glucose uptake, as measured by 2-NBDG (a glucose analog), relative to control islets
• pancreatic islets appear to show altered mitochondrial fission/fusion dynamics, likely due to beta cell immaturity

growth/size/body
N
• 8-week-old mice (male and female combined) exhibit normal body weight relative to age-matched controls





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/25/2025
MGI 6.24
The Jackson Laboratory